1. Home
  2. ANAB vs CWH Comparison

ANAB vs CWH Comparison

Compare ANAB & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$63.70

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Camping World Holdings Inc.

CWH

Camping World Holdings Inc.

HOLD

Current Price

$6.91

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
CWH
Founded
2005
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
ANAB
CWH
Price
$63.70
$6.91
Analyst Decision
Buy
Strong Buy
Analyst Count
12
9
Target Price
$71.67
$15.78
AVG Volume (30 Days)
567.5K
3.1M
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
5.51%
EPS Growth
91.02
N/A
EPS
N/A
3.99
Revenue
$234,603,000.00
$4,792,017,000.00
Revenue This Year
N/A
$4.63
Revenue Next Year
$52.14
$5.72
P/E Ratio
N/A
$1.71
Revenue Growth
157.01
11.83
52 Week Low
$17.11
$5.70
52 Week High
$73.30
$19.64

Technical Indicators

Market Signals
Indicator
ANAB
CWH
Relative Strength Index (RSI) 51.98 46.49
Support Level $53.46 $6.69
Resistance Level $69.56 $7.07
Average True Range (ATR) 5.32 0.49
MACD 0.01 0.04
Stochastic Oscillator 64.47 16.43

Price Performance

Historical Comparison
ANAB
CWH

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.

Share on Social Networks: